Therefore, LPS represents a shared “toxic” mediator of gut-derived inflammation affecting the pancreas (β-cell stress), liver (steatohepatitis), adipose tissue (inflammatory insulin-resistant state), muscles (TLR4-mediated insulin resistance), kidneys (endothelial dysfunction in glomeruli), and brain (hypothalamic inflammation) [57,219]. The gene discussed is INS; the disease is Insulin resistance.